You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Return to C3 Home Page
C3PCRG Investigator List
C3-PCRG Annual Reports
C3-Pancreatic Cancer Research Group
Over the past several years, there has been a tremendous explosion in research activity
around pancreatic cancer at UC San Diego, Sanford-Burnham Medical Research Institute and the Salk Institute. To build on these developments, Dr. Andrew Lowy, Dr. Cosimo Commisso and Dr. Pamela Itkin-Ansari are delighted to announce the formation of the C3- Pancreatic Cancer Research Group (C3-PCRG). This entity will build on the C3 collaborative agreement between UC San Diego Moores Cancer Center and the NCI basic cancer centers at Sanford-Burnham Medical Research Institute and the Salk Institute for Biological Studies.
Our vision is t
o improve the lives of persons diagnosed with pancreatic cancer by innovative research and clinical care.
Our mission is to unite scientists and clinicians committed to pancreatic cancer research and treatment in a highly collaborative environment that accelerates the progress and impact of our work.
We seek to stimulate team science and translational research collaborations in the pancreatic cancer space and;
More closely align basic and clinician researchers working in pancreatic cancer
Accelerate research and translation across campuses
Facilitate sharing of resources such as mouse models, cell lines, and tool compounds
Enable competitive large grant submissions and unique industrial collaborations
Attract new minds to the field from other research areas
Monthly meetings are open to those from both academia and industry, interested in connecting with other investigators. The dates for these meetings are posted on the
and will consist of 1-2 presentation(s) by a basic researcher, clinician or translational researcher, with ample time for questions and discussion.
Regional Therapies Program Manager